End-stage heart failure secondary to low-dose hydroxychloroquine treatment.

Figliozzi, Stefano; Rizzo, Stefania; De Gaspari, Monica; Tarantini, Giuseppe

Figliozzi, Stefano; Rizzo, Stefania; De Gaspari, Monica; Tarantini, Giuseppe.

Afiliación

Figliozzi S; Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Via Giustiniani 2, 35128 Padua, Italy.
Rizzo S; Cardiovascular Pathology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health,University of Padua Medical School Via A. Gabelli, 61 35121 Padua, Italy.
De Gaspari M; Cardiovascular Pathology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health,University of Padua Medical School Via A. Gabelli, 61 35121 Padua, Italy.
Tarantini G; Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Via Giustiniani 2, 35128 Padua, Italy.

Eur Heart J ; 42(2): 207, 2021 01 07.

Article en En | MEDLINE | ID: mdl-32725108

Asunto(s)

COVID-19; Insuficiencia Cardíaca; Insuficiencia Cardíaca/inducido químicamente; Insuficiencia Cardíaca/tratamiento farmacológico; Humanos; Hidroxicloroquina/efectos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Insuficiencia Cardíaca Límite: Humans Idioma: En Revista: Eur Heart J Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google